The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
本公开总体上涉及可用于抑制 MetRS 的组合物,以及通过抑制 MetRS 改善疾病的治疗方法。
SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE
申请人:UNIVERSITY OF WASHINGTON
公开号:US20170275279A1
公开(公告)日:2017-09-28
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
[EN] ANTIMICROBIAL COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS ANTIMICROBIENS ET LEURS PROCÉDÉS D'UTILISATION
申请人:TRIUS THERAPEUTICS
公开号:WO2008098143A2
公开(公告)日:2008-08-14
[EN] The present invention is directed to compounds of formula I, pharmaceutical compositions comprising the compounds, and methods for making and using the inventive compounds. [FR] L'invention concerne des compositions de formule (I), des compositions pharmaceutiques comprenant ces composés, et des procédés de fabrication et d'utilisation de tels composés.
[EN] SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE<br/>[FR] INHIBITEURS SPÉCIFIQUES DE LA MÉTHIONYL-TARN SYNTHÉTASE
申请人:UNIV WASHINGTON
公开号:WO2016029146A1
公开(公告)日:2016-02-25
The present disclosure is generally directed to compositions useful in the inhibition of MetRS and methods for treating diseases that are ameliorated by the inhibition of MetRS.
本公开涉及的是通常用于抑制MetRS的组合物和治疗通过抑制MetRS改善的疾病的方法。
ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
申请人:Li Xiaoming
公开号:US20080194545A1
公开(公告)日:2008-08-14
The present invention is directed to compounds of formula I, pharmaceutical compositions comprising the compounds, and methods for making and using the inventive compounds.